Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Liberty Latin America Class A
LILA
$1.64B
| $124K | ﹤0.01% |
24,181
+14,257
| +144% | +$72.7K |
|
3977
Liberty Broadband Class A
LBRDA
$4.89B
| $123K | ﹤0.01% |
1,625
-4,302
| -73% | -$350K |
|
3978
ACM Research
ACMR
$5.42B
| $122K | ﹤0.01% |
15,874
-79,086
| -83% | -$670K |
|
3979
iShares Core US Aggregate Bond ETF
AGG
$137B
| $122K | ﹤0.01% |
1,258
-12,234
| -91% | -$1.18M |
|
3980
Portillo's
PTLO
$331M
| $122K | ﹤0.01% |
7,475
+6,484
| +654% | +$130K |
|
|
OMGA
3981
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $122K | ﹤0.01% |
21,320
+7,324
| +52% | +$41.1K |
|
|
SWI
3982
DELISTED
SolarWinds Corporation Common Stock
SWI
| $122K | ﹤0.01% |
13,006
+10,958
| +535% | +$95.7K |
|
|
AMRS
3983
DELISTED
Amyris Inc.
AMRS
| $121K | ﹤0.01% |
79,140
+45,424
| +135% | +$101K |
|
|
OBE
3984
Obsidian Energy
OBE
$716M
| $121K | ﹤0.01% |
18,226
+700
| +4% | +$5.44K |
|
3985
nLIGHT
LASR
$3.88B
| $121K | ﹤0.01% |
11,930
+10,046
| +533% | +$104K |
|
3986
Richmond Mutual Bancorp
RMBI
$251M
| $121K | ﹤0.01% |
9,295
-4,072
| -30% | -$53.4K |
|
3987
Bionano Genomics
BNGO
$12.3M
| $120K | ﹤0.01% |
137
+113
| +471% | +$142K |
|
3988
Invesco Semiconductors ETF
PSI
$2.29B
| $120K | ﹤0.01% |
3,591
| – | – |
|
3989
Caesarstone
CSTE
$72.3M
| $120K | ﹤0.01% |
20,952
+5,118
| +32% | +$38.2K |
|
3990
CALL
JetBlue
JBLU
$2.28B
| $119K | ﹤0.01% |
18,400
| – | – |
|
3991
Delek Logistics
DKL
$3.21B
| $119K | ﹤0.01% |
2,629
+2,287
| +669% | +$117K |
|
3992
Victory Capital Holdings
VCTR
$6.19B
| $119K | ﹤0.01% |
4,432
+3,673
| +484% | +$103K |
|
3993
IonQ
IONQ
$13.6B
| $118K | ﹤0.01% |
34,136
+26,320
| +337% | +$127K |
|
|
ABCM
3994
DELISTED
Abcam PLC
ABCM
| $118K | ﹤0.01% |
7,560
-3,228
| -30% | -$50.4K |
|
3995
IDT Corp
IDT
$1.64B
| $117K | ﹤0.01% |
4,167
+1,286
| +45% | +$34.5K |
|
|
BHIL
3996
DELISTED
Benson Hill, Inc.
BHIL
| $117K | ﹤0.01% |
1,313
+1,106
| +534% | +$108K |
|
|
HDSN
3997
Hudson Technologies
HDSN
$254M
| $117K | ﹤0.01% |
11,582
+9,753
| +533% | +$95.3K |
|
|
CTEV
3998
Claritev Corp
CTEV
$387M
| $117K | ﹤0.01% |
2,537
-1,286
| -34% | -$103K |
|
|
SCPL
3999
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $117K | ﹤0.01% |
7,247
+6,838
| +1,672% | +$99.2K |
|
4000
Tarsus Pharmaceuticals
TARS
$2.58B
| $116K | ﹤0.01% |
7,918
+4,157
| +111% | +$68.8K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.